TTR and prostate cancer: For prostate cancer, Suomalainen et al. observed ATTR-positive cardiac uptake in 49 of 1426 patients (3.4%), while Halme et al. reported positivity in 31 of 1013 patients (3.1%) [5,13] (Table 1).